Literature DB >> 8302150

Influence of epinephrine as an adjuvant to epidural morphine for postoperative analgesia.

K S Huang1, C H Tseng, K S Cheung, Y L Hui, P P Tan.   

Abstract

The influence of the addition of epinephrine to epidural morphine on postoperative analgesia were investigated in 60 ASA physical status I or II patients aged average 45 yr. The treatments were given following lower extremity operation under epidural anesthesia with 2% Xylocaine solution in 20 mL. The subjects were randomly divided into 2 groups. Group A (n = 30) received 2 mg epidural morphine in 10 mL normal saline without epinephrine. Group B (n = 30) received 2 mg epidural morphine in 10 mL normal saline with epinephrine 0.1 mg (1:100,000, 10 micrograms/mL). Patients were assessed for quality and duration of postoperative analgesia, as well as the incidence and severity of side effects after epidural morphine administration. The addition of epinephrine to epidural morphine had significantly increased the quality and duration of analgesia. The side effects of pruritus, nausea, vomiting, and urinary retention were more intense after epinephrine-morphine administration. However, respiratory depression was not observed in both groups.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8302150

Source DB:  PubMed          Journal:  Ma Zui Xue Za Zhi


  2 in total

1.  Adding corticosteroids to periarticular infiltration analgesia improves the short-term analgesic effects after total knee arthroplasty: a prospective, double-blind, randomized controlled trial.

Authors:  Qiuru Wang; Gang Tan; Alqwbani Mohammed; Yueyang Zhang; Donghai Li; Liyile Chen; Pengde Kang
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-05-02       Impact factor: 4.342

2.  Adrenergic Agonists Bind to Adrenergic-Receptor-Like Regions of the Mu Opioid Receptor, Enhancing Morphine and Methionine-Enkephalin Binding: A New Approach to "Biased Opioids"?

Authors:  Robert Root-Bernstein; Miah Turke; Udaya K Tiruttani Subhramanyam; Beth Churchill; Joerg Labahn
Journal:  Int J Mol Sci       Date:  2018-01-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.